AU2001243418A1 - Ve-cadherin and vegfr-2 antagonists for therapeutic modulation of angiogenesis - Google Patents

Ve-cadherin and vegfr-2 antagonists for therapeutic modulation of angiogenesis

Info

Publication number
AU2001243418A1
AU2001243418A1 AU2001243418A AU4341801A AU2001243418A1 AU 2001243418 A1 AU2001243418 A1 AU 2001243418A1 AU 2001243418 A AU2001243418 A AU 2001243418A AU 4341801 A AU4341801 A AU 4341801A AU 2001243418 A1 AU2001243418 A1 AU 2001243418A1
Authority
AU
Australia
Prior art keywords
cadherin
vegfr
angiogenesis
antagonists
therapeutic modulation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001243418A
Inventor
Peter Bohlen
Daniel Hicklin
Fang Liao
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ImClone LLC
Original Assignee
ImClone Systems Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ImClone Systems Inc filed Critical ImClone Systems Inc
Publication of AU2001243418A1 publication Critical patent/AU2001243418A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2863—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for growth factors, growth regulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2896—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against molecules with a "CD"-designation, not provided for elsewhere
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AU2001243418A 2000-03-03 2001-03-05 Ve-cadherin and vegfr-2 antagonists for therapeutic modulation of angiogenesis Abandoned AU2001243418A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US18721800P 2000-03-03 2000-03-03
US60187218 2000-03-03
PCT/US2001/006966 WO2001066063A2 (en) 2000-03-03 2001-03-05 Ve-cadherin and vegfr-2 antagonists for therapeutic modulation of angiogenesis

Publications (1)

Publication Number Publication Date
AU2001243418A1 true AU2001243418A1 (en) 2001-09-17

Family

ID=22688074

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001243418A Abandoned AU2001243418A1 (en) 2000-03-03 2001-03-05 Ve-cadherin and vegfr-2 antagonists for therapeutic modulation of angiogenesis

Country Status (2)

Country Link
AU (1) AU2001243418A1 (en)
WO (1) WO2001066063A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100883430B1 (en) 2007-06-13 2009-02-12 한국생명공학연구원 Human Monoclonal Antibody Neutralizing Vesicular Endothelial Growth Factor Receptor and Use Thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5840301A (en) * 1994-02-10 1998-11-24 Imclone Systems Incorporated Methods of use of chimerized, humanized, and single chain antibodies specific to VEGF receptors

Also Published As

Publication number Publication date
WO2001066063A3 (en) 2002-01-03
WO2001066063A2 (en) 2001-09-13

Similar Documents

Publication Publication Date Title
AU3947902A (en) Therapeutic agents and methods of use thereof for the modulation of angiogenesis
EP1283702A4 (en) Medical dressing assembly and associated method of using the same
HUP0303976A3 (en) Combination therapy using anti-egfr antibodies and hormone antagonists
AU2001286940A1 (en) Drug delivering prostheses and methods of use
AU2002232620A1 (en) Therapeutic combination of amlodipine and benazepril/benazeprilat
AU2001282571A1 (en) Waste-gasified fusion furnace and method of operating the fusion furnace
AU2001225816A1 (en) Therapeutic combination of amlodipine and benazepril
MXPA02003174A (en) Novel combination of loteprednol and antihistamines.
AU2001265264A1 (en) Devices and methods for assisting natural heart function
AU2001292864A1 (en) Methods and compositions for modulating angiogenesis
HUP0203957A3 (en) Angiogenesis and vascular permeability modulators and inhibitors
AU2002306918A1 (en) Methods of modulating angiogenesis
AU3771000A (en) Method of promoting angiogenesis
EP1296660A4 (en) The controlled release preparation of insulin and its method
AU2001275707A1 (en) Use of panaxatriol for stimulation angiogenesis
AU8235601A (en) Dispenser and method of use
EP1240201A4 (en) Oxidized apolipoproteins and methods of use
HK1046646A1 (en) Preparations and method of producing the same
GB9929521D0 (en) Bonded products and methods of fabrication therefor
IL151523A0 (en) Use of avocado-soybean unsaponifiable preparations
AU2001243418A1 (en) Ve-cadherin and vegfr-2 antagonists for therapeutic modulation of angiogenesis
AU2001261375A1 (en) Human caspase-12 materials and methods
MXPA03002685A (en) Handle assemblies for floor care devices and methods of using same.
AU6137801A (en) Method and composition for the treatment of angiogenesis
AU2001283486A1 (en) Methods of modulating wound healing and angiogenesis